HK1251902A1 - 橋連哌啶衍生物 - Google Patents
橋連哌啶衍生物Info
- Publication number
- HK1251902A1 HK1251902A1 HK18111223.6A HK18111223A HK1251902A1 HK 1251902 A1 HK1251902 A1 HK 1251902A1 HK 18111223 A HK18111223 A HK 18111223A HK 1251902 A1 HK1251902 A1 HK 1251902A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- piperidine derivatives
- bridged piperidine
- bridged
- derivatives
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15184480 | 2015-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1251902A1 true HK1251902A1 (zh) | 2019-04-26 |
Family
ID=54072754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18111223.6A HK1251902A1 (zh) | 2015-09-09 | 2018-08-31 | 橋連哌啶衍生物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US10604517B2 (zh) |
EP (1) | EP3347363B1 (zh) |
JP (1) | JP6831372B2 (zh) |
CN (1) | CN107922437B (zh) |
AR (1) | AR105965A1 (zh) |
HK (1) | HK1251902A1 (zh) |
TW (1) | TWI716446B (zh) |
WO (1) | WO2017042114A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3347363B1 (en) | 2015-09-09 | 2020-01-01 | H. Hoffnabb-La Roche Ag | N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease |
EP3475279B1 (en) * | 2016-06-27 | 2021-07-14 | F. Hoffmann-La Roche AG | Triazolopyridines as gamma-secretase modulators |
JP6997769B2 (ja) | 2016-09-09 | 2022-02-10 | エフ.ホフマン-ラ ロシュ アーゲー | 2-(6-ニトロピリジン-3-イル)-9H-ジピリド[2,3-b;3’,4’-d]ピロールの製造方法 |
AR109829A1 (es) * | 2016-09-29 | 2019-01-30 | Hoffmann La Roche | Derivados de piperidina puenteados |
CN109476670B (zh) | 2016-10-04 | 2022-06-28 | 豪夫迈·罗氏有限公司 | 二环杂芳基衍生物 |
JP7111704B2 (ja) * | 2016-11-01 | 2022-08-02 | エフ.ホフマン-ラ ロシュ アーゲー | 二環式ヘテロアリール誘導体 |
US11440915B2 (en) | 2017-12-18 | 2022-09-13 | Hoffmann-La Roche Inc. | Triazolo-azepine derivatives |
EP3743428B1 (en) * | 2018-01-22 | 2022-01-19 | F. Hoffmann-La Roche AG | Triazolo-azepine derivatives |
PT3846903T (pt) | 2018-09-03 | 2023-12-14 | Hoffmann La Roche | Derivados heteroarílicos bicíclicos |
US20220056036A1 (en) * | 2018-12-13 | 2022-02-24 | Hoffmann-La Roche Inc. | 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease |
EP3956330A4 (en) | 2019-04-18 | 2023-01-18 | The Johns Hopkins University | SUBSTITUTED 2-AMINO-PYRAZOLYL-[1,2,4]TRIAZOLO[1,5A]PYRIDINE DERIVATIVES AND THEIR USE |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003068776A1 (fr) * | 2002-02-15 | 2003-08-21 | Kyowa Hakko Kogyo Co., Ltd. | Derives de (1, 2, 4) triazolo (1,5-c) pyrimidine |
CA2713716A1 (en) * | 2008-02-22 | 2009-08-27 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
EP2280426B1 (en) * | 2008-04-16 | 2017-07-05 | LG Innotek Co., Ltd. | Light-emitting device |
KR101293421B1 (ko) * | 2008-11-10 | 2013-08-05 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 감마 분비효소 조절제 |
TWI461425B (zh) * | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
NZ596843A (en) * | 2009-05-07 | 2012-12-21 | Janssen Pharmaceuticals Inc | Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators |
WO2010138901A1 (en) * | 2009-05-29 | 2010-12-02 | Biogen Idec Ma Inc | Carboxylic acid-containing compounds, derivatives thereof, and related methods of use |
WO2011050309A2 (en) * | 2009-10-23 | 2011-04-28 | Appsware Wireless, Llc | System and device for consolidating sim, personal token, and associated applications |
US20110190269A1 (en) * | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
US8486967B2 (en) * | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
US8703763B2 (en) * | 2011-03-02 | 2014-04-22 | Hoffmann-La Roche Inc. | Bridged piperidine derivatives |
EP2687528A1 (en) * | 2012-07-17 | 2014-01-22 | Ares Trading S.A. | Fused triazole derivatives as gamma secretase modulators |
EP3347363B1 (en) | 2015-09-09 | 2020-01-01 | H. Hoffnabb-La Roche Ag | N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease |
-
2016
- 2016-09-05 EP EP16763491.4A patent/EP3347363B1/en active Active
- 2016-09-05 JP JP2018512604A patent/JP6831372B2/ja active Active
- 2016-09-05 WO PCT/EP2016/070800 patent/WO2017042114A1/en active Application Filing
- 2016-09-05 CN CN201680051165.9A patent/CN107922437B/zh active Active
- 2016-09-08 TW TW105129076A patent/TWI716446B/zh active
- 2016-09-08 AR ARP160102743A patent/AR105965A1/es unknown
-
2018
- 2018-03-06 US US15/913,087 patent/US10604517B2/en active Active
- 2018-08-31 HK HK18111223.6A patent/HK1251902A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3347363A1 (en) | 2018-07-18 |
JP6831372B2 (ja) | 2021-02-17 |
US20180237432A1 (en) | 2018-08-23 |
TW201718601A (zh) | 2017-06-01 |
EP3347363B1 (en) | 2020-01-01 |
JP2018526410A (ja) | 2018-09-13 |
WO2017042114A1 (en) | 2017-03-16 |
TWI716446B (zh) | 2021-01-21 |
CN107922437A (zh) | 2018-04-17 |
CN107922437B (zh) | 2021-12-10 |
AR105965A1 (es) | 2017-11-29 |
US10604517B2 (en) | 2020-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255045A1 (zh) | 取代的氧代吡啶衍生物 | |
HK1251902A1 (zh) | 橋連哌啶衍生物 | |
IL253381B (en) | History of h9–pyrrolo–dipyridine | |
HK1245258A1 (zh) | 新的二氟酮酰胺衍生物 | |
SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
PT3131898T (pt) | Derivados de fluoroalquilfluoreno | |
IL248773A0 (en) | History of naphthyridinedione | |
IL248629A0 (en) | Substances containing diheteroaryl conjugated to cycloalkyl and their uses | |
PL3418273T3 (pl) | Pochodne flawaglin | |
RS59218B1 (sr) | Novi derivati cyp-eikosanoida | |
IL251005B (en) | Pyrido-oxazinone derivatives | |
PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
HK1251548A1 (zh) | 哌嗪衍生物 | |
HK1259107A1 (zh) | 氨基唑衍生物 | |
PT3319956T (pt) | Derivados de oxopiridina substituída |